FDA Inspection Intelligence
Common FDA Form 483 Observations in
Pharmaceutical Inspections
The inspection findings investigators issue most often — and the questions that lead to them.
During FDA inspections, investigators issue Form 483 observations when conditions may violate GMP requirements.
Most observations are not caused by missing documents.
They occur when investigators cannot determine who authorized a decision, what evidence was reviewed, and which regulatory standard was applied.
Why investigators issue Form 483 observations
During FDA inspections, investigators issue Form 483 observations when conditions appear to violate current Good Manufacturing Practice requirements.
Most observations do not originate from missing documents. They occur when investigators cannot determine who authorized a decision, what evidence was reviewed, and which regulatory standard governed the determination.
When that authorization record cannot be produced at the moment of inspection, the decision becomes difficult to defend.
Regulatory references frequently associated with Form 483 observations
- 21 CFR 211.192 — Investigation of discrepancies
- 21 CFR 211.188 — Batch production and control records
- 21 CFR 211.100 — Written procedures and process controls
- EU Annex 11 — Computerized system validation
- ICH Q10 — Pharmaceutical quality systems
Investigators frequently reference these sections when evaluating whether a compliance decision was properly authorized and documented.
Observation Categories — FDA 21 CFR · EU Annex 11 · GAMP 5
Product Disposition Decisions
Batch Release and Product Disposition
Form 483 Observation
Failure to document evaluation of deviations prior to batch release.
Investigator Question
Who authorized this batch release and what evidence was reviewed before the decision?
See how this inspection question leads to a Form 483 observation in a real inspection scenario.
→ Inspection scenario: Who Authorized This Batch Release?Investigation Closure Decisions
CAPA and Investigation Closure
Form 483 Observation
Corrective actions closed without documented evidence demonstrating effectiveness.
Investigator Question
Who determined this CAPA was effective and what evidence supported that conclusion?
See how this inspection question leads to a Form 483 observation in a real inspection scenario.
→ Inspection scenario: Who Authorized This CAPA Closure?Regulatory Impact Decisions
Change Control and Regulatory Impact
Form 483 Observation
Changes implemented without documented regulatory impact evaluation.
Investigator Question
Who made the regulatory impact determination for this change?
See how this inspection question leads to a Form 483 observation in a real inspection scenario.
→ Inspection scenario: Who Approved This Change Control?Validation and Qualification Decisions
Validation and Qualification
Form 483 Observation
Validation conclusions approved without documented evidence supporting system performance.
Investigator Question
Who authorized the validation conclusion?
See how this inspection question leads to a Form 483 observation in a real inspection scenario.
→ Inspection scenario: Who Authorized the Process Validation Conclusion?Deviation and Root Cause Investigations
Deviation and Root Cause Investigations
Form 483 Observation
Root cause determinations lacked documented evidence supporting the conclusion.
Investigator Question
Who determined the root cause and what evidence supported the determination?
See how this inspection question leads to a Form 483 observation in a real inspection scenario.
→ Inspection scenario: Who Authorized the Root Cause Determination?Example inspection sequence
During an inspection, an investigator reviewed a batch disposition decision.
The batch record existed. The analytical results were present. The release signature was documented.
The investigator then asked:
"Who authorized the release of this batch, and what evidence was reviewed before that decision?"
The organization could not produce a record identifying the decision owner or documenting the evaluation of deviations.
The investigator issued a Form 483 observation.
Inspection event flow
Investigator reviews record
Investigator asks authorization question
Record review — authorization trail sought
Authorization gap identified
Form 483 observation issued
Inspection question sequences
Investigators typically begin with the observation.
They then ask the inspection questions that explain the decision behind the record.
The most common investigator questions are documented in the ComplianceWorxs inspection intelligence library.
View FDA Inspection QuestionsDecision Authorization Model
Quality systems document events.
Investigators evaluate the decisions behind those events.
When the authorization record does not exist at the moment the question is asked, the decision becomes difficult to defend — even when the decision itself was correct.
Understand the Decision Authorization ModelWhat investigators expect to see
When investigators ask who authorized a compliance decision, they expect the record to show:
- The individual responsible for the decision
- The evidence reviewed before authorization
- The regulatory standard applied
- The date and time the decision was authorized
If the authorization record cannot be produced at the moment the question is asked, investigators often document the gap as a Form 483 observation.
Authorization Assessment
If an investigator asked these questions tomorrow,
could your team produce the authorization record immediately?
Most organizations can reconstruct the decision after the fact.
FDA investigators expect the authorization record to already exist.
Free · No account required · Results in under 5 minutes